Autonomic neuropathy in transgenic mice caused by immunotoxin targeting of the peripheral nervous system

Journal of Neuroscience Research

Volumn 51, Issue 2, 1998, Pages 162-173

  Sawada, Hirohide ^a   Nishii, Kazuhiro ^a   Suzuki, Tatsuyo ^a   Hasegawa, Kayo ^a   Hata, Tadayoshi ^a   Nagatsu, Ikuko ^a   Kreitman, Robert J ^b   Pastan, Ira ^b   Nagatsu, Toshiharu ^a   Kobayashi, Kazuto ^a,c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Catecholamine metabolism; Cell targeting; Dopamine hydroxylase; Recombinant immunotoxin; Sympathetic nervous system

Indexed keywords

CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NEUROPATHY; CATECHOLAMINE METABOLISM; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; HEART DISEASE; HYPOTHERMIA; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; CATECHOLAMINES; CHROMATOGRAPHY, GAS; CYTOTOXICITY, IMMUNOLOGIC; DOPAMINE BETA-HYDROXYLASE; HUMANS; IMMUNOTOXINS; INTERLEUKIN-2; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032518239     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980115)51:2<162::AID-JNR5>3.0.CO;2-B     Document Type: Article

References (41)

1. Benedict CR, Fillenz M, Stanford C (1979): Noradrenaline release in rats during prolonged cold-stress and repeated swim-stress. Br J Pharmacol 66:521-524.
2. Batra JK, FitzGerald D, Gately M, Chaudhary VK, Pastan I (1990): Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. J Biol Chem 265:15198-15202.
3. Bradbury S, Eggleston C (1925): Postural hypotension: a report of three cases. Am Heart J 1:73-86.
4. Brinkmann U, Pai LH, FitzGerald DJ, Willingham M, Pastan I (1991): B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA 88:8616-8620.
5. Case JP, Lorberboum-Galski H, Lafyatis R, FitzGerald D, Wilder RL, Pastan I (1989): Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Proc Natl Acad Sci USA 86:287-291.
6. Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan I (1989): A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339:394-397.
7. Fillenz M, Stanford SC, Coles BG (1993): Changes in sympathetic nerve terminals in the heart of cold-exposed rats. J Neurochem 61:132-137.
8. Goetz CG, Lutge W, Tanner CM (1986): Autonomic dysfunction in Parkinson's disease. Neurology 36:73-75.
9. Hogan B, Constantini F, Lacy E (1994): "Manipulating the Mouse Embryo: A Laboratory Manual." 2nd ed. New York: Cold Spring Harbor Laboratory Press.
10. Johnson EM, Cantor E, Douglas JR (1975): Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rats. J Pharmacol Exp Ther 193:503-512.
11. Johnson EM, Hunter FE (1979): Chemical sympathectomy by guanidinium adrenergic neuron blocking agents. Biochem Pharmacol 28:1525-1531.
12. Kobayashi K, Sasaoka T, Morita S, Nagatsu I, Iguchi A, Kurosawa Y, Fujita K, Nomura T, Kimura M, Katsuki M, Nagatsu T (1992): Genetic alteration of catecholamine specificity in transgenic mice. Proc Natl Acad Sci USA 89:1631-1635.
13. Kobayashi K, Morita S, Mizuguchi T, Sawada H, Yamada K, Nagatsu I, Fujita K, Nagatsu T (1994): Functional and high level expression of human dopamine β-hydroxylase in transgenic mice. J Biol Chem 269:29725-29731.
14. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Hata T, Watanabe Y, Fujita K, Nagatsu T (1995a): Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270:27235-27243.
15. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Fujita K, Kreitman RJ, Pastan I, Nagatsu T (1995b): Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. Proc Natl Acad Sci USA 92:1132-1136.
16. Kopin IJ, Polinsky RJ, Oliver JA, Oddershede IR, Ebert MH (1983): Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. J Clin Endocrinol Metab 57:632-637.
17. Kostrzewa RM, Jacobowitz DM (1974): Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26:199-288.
18. Kostrzewa RM (1989): Neurotoxins that affect central and peripheral catecholamine neurons. In Boulton AA, Baker GB, Juorio AV (eds): "Neuromethods Vol.12: Drugs as Tools in Neurotransmitter Research." Clifton, NJ: Humana Press, pp 1-48.
19. Kreitman RJ, Bailon P, Chaudhary VK, FitzGerald DJP, Pastan I (1994a): Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood 83:426-434.
20. Kreitman RJ, Chang CN, Hudson DV, Queen C, Bailon P, Pastan I (1994b): Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model. Int J Cancer 57:856-864.
21. Kumer SC, Vrana KE (1996): Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-4-62.
22. Kvetnǎnský R, Mikulaj L (1970): Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 87:738-743.
23. Lorberboum-Galski H, Barrett LV, Kirkman RL, Ogata M, Willincham MC, FitzGerald DJ, Pastan I (1989): Cardiac allograft survixal in mice treated with IL-2-PE40. Proc Natl Acad Sci USA 86: 1008-1012.
24. Masserano JM, Takimoto GS, Weiner N (1981): Electroconvulsive shock increases tyrosine hydroxylase activity in the brain and adrenal gland of the rat. Science 214:662-665.
25. Mathias CJ (1995): Classification of autonomic nervous system dysfunction. In Korczyn AD (ed) "Handbook of Autonomie Nervous System Dysfunction." New York: Marcel Dekker, pp 53-60.
26. Morita S, Kobayashi K, Mizuguchi T, Yamada K, Nagatsu I, Titani K, Fujita K, Hidaka H, Nagatsu T (1993): The 5'-flanking region of the human dopamine β-hydroxylase gene promotes neuron subtype-specific gene expression in the central nervous system of transgenic mice. Mol Brain Res 17:239-244.
27. Nabeshima T, Itoh A, Kobayashi K, Morita S, Mizuguchi T, Sawada H, Nitta A, Hasegawa T, Hayashi K, Nagatsu T (1994): Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene. J Neural Transm 97:41-49.
28. Nagatsu I, Komori K, Miura K, Sakai M, Karasawa N, Yamada K (1989): Ontogeny of phenylethanolamine-N-methyltransferase and tyrosine hydroxylase-immunoreactive expression in the mouse anterior olfactory nucleus. Biomed Res 10:277-286.
29. Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T (1984): Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311-6.31-635.
30. Pai LH, Batra JK, FitzGerald DJ, Willingham MC, Pastan I (1992): Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys. Cancer Res 52:3189-3193.
31. Pai LH, Wittes R, Setser A, Willingham MC, Pastan I (1996): Treatment of advanced solid tumors with immunotoxin LMB-1: An antibody linked to Pseudomonas exotoxin. Nature Med 2:350-353.
32. Picklo MJ, Willey RG, Lappi DA, Robertson D (1994): Noradrenergic lesioning with an anti-dopamine β-hydroxylase immunotoxin. Brain Res 666:195-200.
33. Picklo MJ, Willey RG, Lonce S, Lappi DA, Robertson D (1995): Anti-dopamine β-hydroxylase immunotoxin-induced sympathectomy in adults rats. J Pharmacol Exp Ther 275:1005-1010.
34. Rajput AH, Rozdilsky B (1976): Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psych 39:1092-1100.
35. Randall WC (1977): Sympathetic control of the heart. In Randall WC (cd): "Neural Regulation of the Heart." New York: Oxford University Press, pp 43-92.
36. Robertson D, Beck C, Gary T, Picklo M (1993): Classification of autonomic disorders. Int Angiol 12:93-102.
37. Robertson D, Hollister AS, Biaggioni I (1990): Dopamine-β-hydroxylase deficiency and cardiovascular control. In Laragh JH, Brenner BM (eds): "Hypertension: Pathophysiology, Diagnosis, and Management." New York: Raven Press, pp 749-759.
38. Shy GM, Drager GA (1960): A neurological syndrome associated with orthostatic hypotension. Arch Neurol 3:511-527.
39. Thomas SA, Matsumoto AM, Palmiter RD (1995): Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
40. Zhou Q-Y, Quaife CJ, Palmiter RD (1995): Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640-643.
41. Ziegler MG, Lake CR, Kopin IJ (1977): The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 296:293-297.